Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.

Lebreton C, Ménard S, Abed J, Moura IC, Coppo R, Dugave C, Monteiro RC, Fricot A, Traore MG, Griffin M, Cellier C, Malamut G, Cerf-Bensussan N, Heyman M.

Gastroenterology. 2012 Sep;143(3):698-707.e1-4. doi: 10.1053/j.gastro.2012.05.051. Epub 2012 Jun 28.

PMID:
22750506
2.

Larazotide acetate promotes tight junction assembly in epithelial cells.

Gopalakrishnan S, Tripathi A, Tamiz AP, Alkan SS, Pandey NB.

Peptides. 2012 May;35(1):95-101. doi: 10.1016/j.peptides.2012.02.016. Epub 2012 Feb 28.

PMID:
22401910
3.

Larazotide acetate regulates epithelial tight junctions in vitro and in vivo.

Gopalakrishnan S, Durai M, Kitchens K, Tamiz AP, Somerville R, Ginski M, Paterson BM, Murray JA, Verdu EF, Alkan SS, Pandey NB.

Peptides. 2012 May;35(1):86-94. doi: 10.1016/j.peptides.2012.02.015. Epub 2012 Feb 27.

PMID:
22401908
4.

Non-dietary therapeutic clinical trials in coeliac disease.

Crespo Pérez L, Castillejo de Villasante G, Cano Ruiz A, León F.

Eur J Intern Med. 2012 Jan;23(1):9-14. doi: 10.1016/j.ejim.2011.08.030. Epub 2011 Sep 29. Review.

PMID:
22153524
5.

Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials.

Siegel M, Garber ME, Spencer AG, Botwick W, Kumar P, Williams RN, Kozuka K, Shreeniwas R, Pratha V, Adelman DC.

Dig Dis Sci. 2012 Feb;57(2):440-50. doi: 10.1007/s10620-011-1906-5. Epub 2011 Sep 23.

PMID:
21948339
6.

Cell polarity-determining proteins Par-3 and PP-1 are involved in epithelial tight junction defects in coeliac disease.

Schumann M, Günzel D, Buergel N, Richter JF, Troeger H, May C, Fromm A, Sorgenfrei D, Daum S, Bojarski C, Heyman M, Zeitz M, Fromm M, Schulzke JD.

Gut. 2012 Feb;61(2):220-8. doi: 10.1136/gutjnl-2011-300123. Epub 2011 Aug 24.

PMID:
21865402
7.

Are patients with coeliac disease seeking alternative therapies to a gluten-free diet?

Aziz I, Evans KE, Papageorgiou V, Sanders DS.

J Gastrointestin Liver Dis. 2011 Mar;20(1):27-31.

8.

Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2.

Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, Arrietta MC, Meddings JB, Fasano A.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16799-804. doi: 10.1073/pnas.0906773106. Epub 2009 Sep 15.

9.

Surprises from celiac disease.

Fasano A.

Sci Am. 2009 Aug;301(2):54-61. No abstract available.

PMID:
19634568
10.

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.

Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB.

Aliment Pharmacol Ther. 2007 Sep 1;26(5):757-66.

11.

A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.

Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A.

Am J Clin Nutr. 2007 Jan;85(1):160-6.

12.

Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.

Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, Thakar M, Iacono G, Carroccio A, D'Agate C, Not T, Zampini L, Catassi C, Fasano A.

Scand J Gastroenterol. 2006 Apr;41(4):408-19.

PMID:
16635908
13.

Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease.

Hischenhuber C, Crevel R, Jarry B, Mäki M, Moneret-Vautrin DA, Romano A, Troncone R, Ward R.

Aliment Pharmacol Ther. 2006 Mar 1;23(5):559-75. Review.

14.

Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases.

Fasano A, Shea-Donohue T.

Nat Clin Pract Gastroenterol Hepatol. 2005 Sep;2(9):416-22. Review.

PMID:
16265432
15.

Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.

Watts T, Berti I, Sapone A, Gerarduzzi T, Not T, Zielke R, Fasano A.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2916-21. Epub 2005 Feb 14.

16.

Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.

Qiao SW, Bergseng E, Molberg Ø, Xia J, Fleckenstein B, Khosla C, Sollid LM.

J Immunol. 2004 Aug 1;173(3):1757-62.

17.

The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease?

Collin P, Thorell L, Kaukinen K, Mäki M.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1277-83. Review.

18.

Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients.

Di Cagno R, De Angelis M, Auricchio S, Greco L, Clarke C, De Vincenzi M, Giovannini C, D'Archivio M, Landolfo F, Parrilli G, Minervini F, Arendt E, Gobbetti M.

Appl Environ Microbiol. 2004 Feb;70(2):1088-96.

19.

Weight maintenance and relapse in obesity: a qualitative study.

Byrne S, Cooper Z, Fairburn C.

Int J Obes Relat Metab Disord. 2003 Aug;27(8):955-62.

PMID:
12861237
20.

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.

Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, Londei M.

Lancet. 2003 Jul 5;362(9377):30-7.

PMID:
12853196
Items per page

Supplemental Content

Write to the Help Desk